In 2008, we presented the first evidence for the expression of APRIL and BAFF in specimens of breast cancer patients and reported the expression of these molecules in human epithelial breast cancer cells (133), repositioning the established notion that the major source of APRIL was either stroma cells (68) or infiltrating neutrophils (132). This evidence concerns the gene TNFSF13 and breast carcinoma.